Ligand Pharmaceuticals In shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $310k | 2.9k | 105.14 |
| 2024-12-31 | $2.5M | 24k | 107.15 |
| 2024-09-30 | $2.7M | 27k | 100.09 |
| 2024-06-30 | $1.5M | 17k | 84.26 |
| 2024-03-31 | $1.8M | 24k | 73.10 |
| 2020-03-31 | $249k | 3.4k | 72.70 |
| 2018-12-31 | $1.2M | 8.8k | 135.75 |
| 2018-09-30 | $247k | 900 | 274.44 |
| 2014-12-31 | $367k | 6.9k | 53.19 |
| 2014-09-30 | $564k | 12k | 47.00 |
| 2014-06-30 | $1.1M | 17k | 66.34 |
| 2014-03-31 | $3.7M | 49k | 74.25 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management